Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-145,970
Closed -$11.6M 289
2021
Q4
$11.6M Buy
145,970
+18,926
+15% +$1.58M 0.33% 84
2021
Q3
$10M Buy
127,044
+6,806
+6% +$547K 0.31% 88
2021
Q2
$9.48M Buy
+120,238
New +$9.21M 0.28% 91

Other funds holding ENOV

Cannell & Co's ENOV Position: Q1 2022 in Review

Cannell & Co sold out of Enovis (ENOV) in Q1 2022, closing a stake of 145,970 shares — an estimated $11.6M sold.

Cannell & Co first reported a position in ENOV in Q2 2021 and held it in 3 quarters. The position peaked at $11.6M in Q4 2021. 298 funds tracked by Wall St. Rank hold ENOV as of Q1 2022.

  • Cannell & Co reported no remaining Enovis position as of Q1 2022 after selling out during the quarter.
  • Cannell & Co sold 145,970 Enovis shares in Q1 2022, an estimated $11.6M.
  • Cannell & Co first reported a position in Enovis in Q2 2021 and held it in 3 quarters.
  • Cannell & Co's Enovis position peaked at $11.6M in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Enovis as of Q1 2022.

Based on Cannell & Co's 13F filing for Q1 2022, filed 10 May 2022.